-
META-ANALYSIS OF QUALITY OF LIFE AMONG PATIENTS WITH HEPATITIS C WITH OR WITHOUT SUSTAINED VIROLOGICAL RESPONSE
Mar 18, 2026, 21:38 PM -
ALTERNATIVE PAYMENT MODELS IN CARDIOLOGY: A SCOPING REVIEW OF DESIGN FEATURES, QUALITY OUTCOMES, AND COSTS
Mar 18, 2026, 21:38 PM -
FROM PROMPT ENGINEERING TO DECISION-MAKING: ARTIFICIAL INTELLIGENCE IN HEALTH TECHNOLOGY ASSESSMENT
Mar 18, 2026, 21:38 PM -
COMPARING THE DISEASE BURDEN OF MIGRAINE BETWEEN USERS OF CGRP MONOCLONAL ANTIBODIES AND PREVENTIVE GEPANTS
Mar 18, 2026, 21:38 PM -
ESTIMATING THE FINANCIAL IMPACT OF DUPILUMAB FOR COPD USING REAL-WORLD CLAIMS DATA: A PROBABILISTIC BUDGET IMPACT ANALYSIS IN THE BRAZILIAN PRIVATE HEALTH SYSTEM
Mar 18, 2026, 21:38 PM -
SOCIODEMOGRAPHIC AND CLINICAL CHARACTERISTICS OF LATANOPROSTENE BUNOD INITIATORS AMONG MEDICARE FEE-FOR-SERVICE PATIENTS WITH OPEN ANGLE GLAUCOMA AND OCULAR HYPERTENSION
Mar 18, 2026, 21:38 PM -
CONCEPTUAL COST-EFFECTIVENESS FRAMEWORK FOR GMRX2 (TELMISARTAN/AMLODIPINE/INDAPAMIDE) AS EARLY COMBINATION THERAPY FOR US ADULTS WITH HYPERTENSION WITHOUT MAJOR ATHEROSCLEROTIC CARDIOVASCULAR DISEASE, USED EITHER AT INITIATION OR AS A STEP-UP FROM...
Mar 18, 2026, 21:38 PM -
REAL-WORLD EFFECTIVENESS OF DUPILUMAB IN REDUCING ORAL AND INHALED CORTICOSTEROID USE AMONG US PATIENTS WITH ASTHMA: ANALYSIS FROM THE HEALTHCARE INTEGRATED RESEARCH DATABASE
Mar 18, 2026, 21:38 PM -
GENERAL-PURPOSE VS HEOR-SPECIFIC GENERATIVE AI IN RARE DISEASE MODELING: A DUCHENNE MUSCULAR DYSTROPHY CASE STUDY
Mar 18, 2026, 21:38 PM -
UPDATING SYSTEMATIC LITERATURE REVIEWS AND REPORTS USING A GENERATIVE AI-ENABLED FRAMEWORK
Mar 18, 2026, 21:38 PM -
CAN A GENERATIVE PATIENT JOURNEY FOUNDATION MODEL ALLEVIATE THE BURDEN OF CANCER SCREENING?
Mar 18, 2026, 21:38 PM -
HOW THE EU JOINT CLINICAL ASSESSMENT UNCERTAINTIES IMPACT US PHARMACEUTICAL MARKET ACCESS
Mar 18, 2026, 21:38 PM -
REAL-WORLD DATA IN DEMENTIA RESEARCH: IMPLICATIONS FOR HEALTH ECONOMICS AND OUTCOMES RESEARCH
Mar 18, 2026, 21:38 PM -
STRENGTHENING MATERNAL CARE SYSTEMS IN LOW- AND MIDDLE-INCOME COUNTRIES: MODELING THE ACCESS, HEALTH, AND ECONOMIC IMPACT OF SFLT-1/PLGF TESTING FOR PREECLAMPSIA
Mar 18, 2026, 21:38 PM -
HEALTHCARE RESOURCE UTILIZATION AND COSTS IN JAPANESE PATIENTS WITH GENERALIZED MYASTHENIA GRAVIS INITIATING EFGARTIGIMOD: A REAL-WORLD RETROSPECTIVE ANALYSIS
Mar 18, 2026, 21:38 PM -
DYNAMIC PRICING IN THE CONTEXT OF COST-EFFECTIVENESS MODELING AND WILLINGNESS-TO-PAY THRESHOLDS
Mar 18, 2026, 21:38 PM -
PRE-APPROVAL INFORMATION EXCHANGE (PIE) IN THE UNITED STATES. TRENDS FOLLOWING THE PASSAGE OF THE PIE ACT: WHERE ARE WE NOW?
Mar 18, 2026, 21:38 PM -
IMPACT OF GOLD-GUIDED PHARMACIST-LED PHARMACEUTICAL CARE ON CLINICAL OUTCOMES AND QUALITY OF LIFE IN COPD: A PROSPECTIVE RANDOMIZED TRIAL
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS OF SCREENING AND INTERVENTION STRATEGIES FOR PERINATAL DEPRESSION USING MULTI-STATE MARKOV MODEL IN RURAL CHINA
Mar 18, 2026, 21:38 PM -
EXAMINING PLAN-LEVEL BID DEVIATIONS IN MEDICARE PART D: EVIDENCE FROM 2016-2025
Mar 18, 2026, 21:38 PM
